Mode
Text Size
Log in / Sign up

Brain bank series finds 47% clinical-pathological concordance in primary tauopathies

Brain bank series finds 47% clinical-pathological concordance in primary tauopathies
Photo by ClinicalPulse / Unsplash
Key Takeaway
Note the low clinical-pathological concordance and marked heterogeneity in primary tauopathies from a small brain bank series.

This systematic review analyzed the clinicopathological features of primary tauopathies in a series of 15 brain donation cases from a single national brain bank (Neurological Foundation Human Brain Bank) collected between 1994 and 2022. The study aimed to identify cases and analyze their features, with no specific intervention or comparator reported. The identified tauopathies included argyrophilic grain disease, primary age-related tauopathy, corticobasal degeneration, genetic frontotemporal dementia, and progressive supranuclear palsy.

The main findings show a mean age of onset of 69 years and an average survival of 6 years. A key result was that only 47% of cases had concordance between the clinical diagnosis made during life and the final post-mortem neuropathological diagnosis. The neuropathological findings revealed marked diversity in tau pathology and regional vulnerability, with most cases demonstrating both neuronal and glial tau pathology.

Safety and tolerability data were not reported. The study's key limitations, as noted, include its nature as a single brain bank series, retrospective analysis, and small sample size of only 15 cases. These factors significantly limit the generalizability of the findings.

In practice, this work highlights the complexity and heterogeneity of primary tauopathies and reinforces the critical role of post-mortem neuropathological examination for definitive diagnosis. The low clinical-pathological concordance rate suggests that antemortem diagnosis remains challenging. Clinicians should interpret these findings cautiously due to the observational nature and limited scope of the evidence.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMar 2026
View Original Abstract ↓
IntroductionThis study presents the first comprehensive clinicopathological analysis of primary tauopathies from the Neurological Foundation Human Brain Bank (NFHuBB). Primary tauopathies are a heterogeneous group of neurodegenerative disorders, defined by abnormal tau protein deposition as the core pathological feature. They are further defined by the absence of an additional pathological driver. Historically, they were often accepted into brain banks as Alzheimer’s, Parkinson’s, or dementia cases.MethodsHere, we retrospectively examined all brain donations to the NFHuBB from 1994 to 2022 to identify cases of primary tauopathy, excluding those with known secondary causes such as repetitive head trauma. This is a national-level, single brain bank series. Detailed clinical records, demographic data, and post-mortem pathological investigations, including immunohistochemistry, were analysed to establish clinical and pathological diagnoses according to current criteria.ResultsFifteen cases were identified, spanning argyrophilic grain disease, primary age-related tauopathy, corticobasal degeneration, genetic frontotemporal dementia, and progressive supranuclear palsy. The mean age of onset was 69 years, with average survival of 6 years. Notably, only 47% of cases showed concordance between clinical and pathological diagnosis, underscoring diagnostic challenges. Neuropathological review revealed marked diversity in tau pathology and regional vulnerability, with most cases demonstrating both neuronal and glial tau pathology.DiscussionThis case series highlights the complexity and heterogeneity of primary tauopathies and the critical role of post-mortem neuropathological examination for diagnosis. By making fixed and frozen tissue, and clinical data available for national and international dissemination, this study provides a valuable resource to advance global research into the pathogenesis and classification of tauopathies. Furthermore, this work highlights the important role of brain banking in the study of rare diseases.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.